Clinical Trials
8 trialsNCT07308379 2025-12-29
Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer
Fudan University
Not yet recruiting
NCT06991790 2025-05-28
Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration
Peking University Cancer Hospital & Institute
Recruiting
NCT06333561 2025-02-06
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
Sun Yat-sen University
Recruiting
NCT04627012 2024-03-06
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Completed
NCT06009705 2023-08-24
Best-EEC
Hebei Medical University Fourth Hospital
Unknown
NCT05652712 2022-12-15
A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)
Qianfoshan Hospital
Unknown
NCT04771715 2021-02-25
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
Peking Union Medical College Hospital
Unknown
NCT04234620 2020-01-21
Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
Shanghai Junshi Bioscience Co., Ltd.
Unknown